Effects of Stereotype Threat on Impulsivity and Its Relation to Alcohol Use in African Americans: An fMRI Study
2 other identifiers
interventional
280
1 country
1
Brief Summary
The purpose of this study is to investigate the behavioral and neural correlates of stress exposure. Results from this study will enrich the understanding of how sociocultural, behavioral, and neural factors combine to influence alcohol use.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 9, 2022
CompletedFirst Submitted
Initial submission to the registry
December 22, 2022
CompletedFirst Posted
Study publicly available on registry
January 9, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2026
CompletedApril 13, 2025
April 1, 2025
3.1 years
December 22, 2022
April 10, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Blood oxygen-level dependent (BOLD) signal
Blood oxygen-level dependent (BOLD) signal in brain regions of interest (ROI) measured using fMRI
Baseline
Resting-state functional connectivity in brain regions
Resting-state functional connectivity - brain activity measured using fMRI
Baseline
Study Arms (2)
no stress exposure
PLACEBO COMPARATORno threat stress
stress exposure
ACTIVE COMPARATORexposure to stress threat
Interventions
Brief behavioral intervention is absent of stressors.
Eligibility Criteria
You may qualify if:
- Between 21 and 35 years of age (inclusive);
- Fluent in English;
- Right-handed
You may not qualify if:
- Younger than 21 years of age;
- Left-handed
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Icahn School of Medicine at Mount Sinai
New York, New York, 10029, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Uraina Clark, PhD
Icahn School of Medicine at Mount Sinai
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
December 22, 2022
First Posted
January 9, 2023
Study Start
December 9, 2022
Primary Completion
January 31, 2026
Study Completion
January 31, 2026
Last Updated
April 13, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share
There is no plan to share IPD